Important notice
We would like to inform you that Chinese Journal of Cancer has changed the title to Cancer Communications on 1st March 2018.
Please click the links below for more information of Cancer Communications
http://www.cancercommin.com
https://cancercommun.biomedcentral.com
About the cover
pISSN: 1000-467X
eISSN: 1944-446X
CN: 44-1195/R
View OnlineFirst Articles
New articles accepted recently
View Current Issue
Volume 36 Issue 12
Browse Past Issues
From January 2002
In this issue
Awakening immunity against cancer: a 2017 primer for clinicians
Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer: a multicenter, randomized, double-blinded, placebo-controlled, phase II clinical trial
Systematic analyses of glutamine and glutamate metabolisms across different cancer types
[查看详情]